Cristea, Mihaela C. http://orcid.org/0000-0003-2580-530X
Frankel, Paul
Synold, Timothy
Rivkin, Saul
Lim, Dean
Chung, Vincent
Chao, Joseph
Wakabayashi, Mark
Paz, Benjamin
Han, Ernest
Lin, Paul
Leong, Lucille
Hakim, Amy
Carroll, Mary
Prakash, Neal
Dellinger, Thanh
Park, Min
Morgan, Robert J.
Clinical trials referenced in this document:
Documents that mention this clinical trial
A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity
https://doi.org/10.1007/s00280-019-03767-9
Funding for this research was provided by:
National Cancer Institute of the National Institutes of Health (P30CA033572)
Celgene (General Research Support)
National Comprehensive Cancer Network (NCCNMIRV0016)
Article History
Received: 30 August 2018
Accepted: 2 January 2019
First Online: 8 January 2019
Compliance with ethical standards
:
: MC receives personal fees from Astra Zeneca and VC is a member of the Celgene Speaker’s Bureau.
: All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.